Login to Your Account

Amgen Furloughs 380, Shifts Resources to Late-Stage Programs

By Tom Wall

Friday, October 21, 2011
Amgen Inc. will lay off about 380 employees at several R&D sites and shift resources to several late-stage programs. The furloughs, effective Dec. 30, involve about 2 percent of the giant biotech's roughly 17,600 employees worldwide.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription